Using Tissue Concentrations of Therapies in Inflammatory Bowel Disease Studies
Author Information
Author(s): Bayoumy Ahmed B., Derijks Luc J. J., Oldenburg Bas, de Boer Nanne K. H.
Primary Institution: Amsterdam University Medical Center
Hypothesis
Can tissue concentrations of biological and small-molecule therapies improve treatment strategies for inflammatory bowel disease?
Conclusion
Exploring tissue drug concentrations may enhance understanding of pharmacotherapy in inflammatory bowel disease.
Supporting Evidence
- Tissue concentrations may provide valuable insights into drug pharmacology in inflammatory bowel disease.
- Current evidence suggests that tissue concentration measurements have no established role in clinical practice.
Takeaway
This study looks at how measuring drug levels in tissues can help doctors understand and treat inflammatory bowel disease better.
Methodology
The study reviews various methods for measuring tissue drug concentrations and discusses their implications for treatment in inflammatory bowel disease.
Limitations
The routine use of tissue concentration measurements in clinical practice is not yet established due to challenges in validation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website